Orthofix Medical Inc. Files 2025 Proxy Statement
Ticker: OFIX · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 884624
Sentiment: neutral
Topics: proxy-statement, executive-compensation, governance
TL;DR
Orthofix proxy filing out, exec comp details for 2024 released. Vote your shares!
AI Summary
Orthofix Medical Inc. filed a DEF 14A on April 30, 2025, detailing executive compensation and board member information for the fiscal year ending December 23, 2024. The filing includes details on equity awards and compensation for individuals such as Jon C. Serbousek, Catherine Burzik, Keith C. Valentine, and Massimo Calafiore. It also references prior fiscal years, including 2022 and 2023, for comparative compensation data.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and board governance, enabling informed voting decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing providing information on executive compensation and board matters, not indicating new financial risks.
Key Numbers
- 2024 — Fiscal Year End (Primary period for compensation data in this filing)
- 20250430 — Filing Date (Date the DEF 14A was submitted to the SEC)
Key Players & Entities
- Orthofix Medical Inc. (company) — Filer of the DEF 14A
- Jon C. Serbousek (person) — Executive/Board Member mentioned in compensation details
- Catherine Burzik (person) — Executive/Board Member mentioned in compensation details
- Keith C. Valentine (person) — Executive/Board Member mentioned in compensation details
- Massimo Calafiore (person) — Executive/Board Member mentioned in compensation details
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
Who are the key individuals whose compensation is detailed in this filing?
The filing mentions Jon C. Serbousek, Catherine Burzik, Keith C. Valentine, and Massimo Calafiore in the context of compensation and equity awards.
What fiscal year does the compensation data primarily cover?
The compensation data and related discussions in this filing primarily cover the fiscal year ending December 23, 2024.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 30, 2025.
What is Orthofix Medical Inc.'s primary business sector?
Orthofix Medical Inc. operates in the Surgical & Medical Instruments & Apparatus industry, with SIC code 3841.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 by Jon C. Serbousek regarding Orthofix Medical Inc. (OFIX).